Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Non-invasive Prenatal Testing Market Size Shifted, And What Is the Outlook Through 2034?

The market size for non-invasive prenatal testing has experienced swift expansion in the recent past. It is projected to increase from a value of $5.48 billion in 2024 to $6.27 billion in 2025, progressing at a compound annual growth rate (CAGR) of 14.5%. Factors such as enhanced precision, diminished risk, rising maternal age, heightened awareness, and clinical guidelines have contributed to the growth trajectory in the historic period.

In the forthcoming years, a significant expansion is expected in the non-invasive prenatal testing market size, which is anticipated to grow to$10.86 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%. Factors such as a wider range of tests, enhanced accessibility, increasing age of mothers, the detection of fetal anomalies, and the rise of telemedicine and digital health are contributing to this growth. Future trends forecasting this period include the proliferation of test panels, a broader implementation of non-invasive prenatal testing (nipt), advancements in technology, and non-invasive fetal aneuploidy diagnosis (nifad).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Non-invasive Prenatal Testing Market?

The non-invasive prenatal testing market is predominantly driven by the high prevalence of Down syndrome, a circumstance which is exacerbated by an increase in the average maternal age. There is a growing concern over the health and development of the fetus as the age of the mother increases. Down syndrome is a chromosomal disorder that results from an error in cell division, leading to an additional 21st chromosome, which can impact the cognitive and physical growth of the fetus. Non-invasive prenatal testing (NIPT) has emerged as a safe method of screening for Down Syndrome, as it poses no risk to the mother or the baby and does not cause miscarriage. Moreover, NIPT can detect over 99% of Down syndrome cases. Based on statistics from the National Down Syndrome Society and the Centers for Disease Control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome, and 80% of these children are born to mothers who are older. This higher risk of having a baby with Down syndrome among older women is fueling the expansion of the non-invasive prenatal testing market.

Which Key Market Segments Comprise the Non-invasive Prenatal Testing Market and Drive Its Revenue Growth?

The non-invasive prenatal testingmarket covered in this report is segmented –

1) By Type: Consumables; Instruments

2) By Application: Trisomy; Microdeletion; Genetics; Rh factor

3) By End User: Hospital; Diagnostic Labs

Subsegments:

1) By Consumables: Assay Kits; Reagents; Disposables

2) By Instruments: Next-Generation Sequencers (NGS); Polymerase Chain Reaction (PCR) Systems; Ultrasound Devices; Others (Microarrays And Mass Spectrometers)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp

Which Areas Are Leading Regions in the Non-invasive Prenatal Testing Market Expansion Across the Globe?

North America was the largest region in the non-invasive prenatal testing market in 2024. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theNon-invasive Prenatal Testing Market Over the Coming Years?

The advent of next-generation sequencing has significantly amplified the efficiency, scalability, and speed of research, allowing scientists to execute diverse applications and thoroughly investigate biological systems. This groundbreaking technology facilitates the simultaneous sequencing of thousands to millions of DNA molecules. Producers have adopted this technology as a cost and time-effective solution that enhances the output for results relating to genome and DNA testing. Leading players such as Illumina, Eurofins, Natera, Roche, and Annoroad have incorporated this technology in non-invasive prenatal testing. The next-generation sequencing instrument, NextSeq 550AR, manufactured by Annoroad, has received approved medical instrument product registration from CFDA (China Food and Drug Administration).

View the full report here:

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

How Is the Non-invasive Prenatal Testing Market Conceptually Defined?

Non-invasive prenatal testing is a test in which blood from the mother is drawn and tested for possible abnormalities in the patient. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects, in fetuses in the first trimester of pregnancy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2492

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model